ArticleNature communications2022

CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity.

Julia Joung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.